173 related articles for article (PubMed ID: 38070928)
1. Effect of whole-body cryotherapy versus placebo cryotherapy on joint pain induced by aromatase inhibitors in women with early stage breast cancer: a randomised clinical trial.
Duraes M; Garbay M; Ferrer C; Duflos C; Rathat G
BMJ Open; 2023 Dec; 13(12):e071756. PubMed ID: 38070928
[TBL] [Abstract][Full Text] [Related]
2. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.
Hershman DL; Unger JM; Greenlee H; Capodice JL; Lew DL; Darke AK; Kengla AT; Melnik MK; Jorgensen CW; Kreisle WH; Minasian LM; Fisch MJ; Henry NL; Crew KD
JAMA; 2018 Jul; 320(2):167-176. PubMed ID: 29998338
[TBL] [Abstract][Full Text] [Related]
3. A randomised trial of electro-acupuncture for arthralgia related to aromatase inhibitor use.
Mao JJ; Xie SX; Farrar JT; Stricker CT; Bowman MA; Bruner D; DeMichele A
Eur J Cancer; 2014 Jan; 50(2):267-76. PubMed ID: 24210070
[TBL] [Abstract][Full Text] [Related]
4. Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.
Hershman DL; Unger JM; Crew KD; Awad D; Dakhil SR; Gralow J; Greenlee H; Lew DL; Minasian LM; Till C; Wade JL; Meyskens FL; Moinpour CM
J Clin Oncol; 2015 Jun; 33(17):1910-7. PubMed ID: 25940724
[TBL] [Abstract][Full Text] [Related]
5. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.
Crew KD; Capodice JL; Greenlee H; Brafman L; Fuentes D; Awad D; Yann Tsai W; Hershman DL
J Clin Oncol; 2010 Mar; 28(7):1154-60. PubMed ID: 20100963
[TBL] [Abstract][Full Text] [Related]
6. Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202.
Henry NL; Unger JM; Schott AF; Fehrenbacher L; Flynn PJ; Prow DM; Sharer CW; Burton GV; Kuzma CS; Moseley A; Lew DL; Fisch MJ; Moinpour CM; Hershman DL; Wade JL
J Clin Oncol; 2018 Feb; 36(4):326-332. PubMed ID: 29136387
[TBL] [Abstract][Full Text] [Related]
7. Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer: A meta-analysis of randomized controlled trials.
Chen L; Lin CC; Huang TW; Kuan YC; Huang YH; Chen HC; Kao CY; Su CM; Tam KW
Breast; 2017 Jun; 33():132-138. PubMed ID: 28384564
[TBL] [Abstract][Full Text] [Related]
8. Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
Roberts KE; Rickett K; Feng S; Vagenas D; Woodward NE
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012988. PubMed ID: 31994181
[TBL] [Abstract][Full Text] [Related]
9. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors.
Irwin ML; Cartmel B; Gross CP; Ercolano E; Li F; Yao X; Fiellin M; Capozza S; Rothbard M; Zhou Y; Harrigan M; Sanft T; Schmitz K; Neogi T; Hershman D; Ligibel J
J Clin Oncol; 2015 Apr; 33(10):1104-11. PubMed ID: 25452437
[TBL] [Abstract][Full Text] [Related]
10. Randomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trial.
Lustberg M; Fan-Havard P; Wong FL; Hill K; Phelps MA; Herrera KW; Tsai NC; Synold T; Feng Y; Kalu C; Sedrak MS; Yee LD
Breast Cancer Res Treat; 2024 May; 205(1):61-73. PubMed ID: 38280052
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial.
Rastelli AL; Taylor ME; Gao F; Armamento-Villareal R; Jamalabadi-Majidi S; Napoli N; Ellis MJ
Breast Cancer Res Treat; 2011 Aug; 129(1):107-16. PubMed ID: 21691817
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients: a protocol for a systematic review and network meta-analysis.
Bae K; Song SY
BMJ Open; 2020 May; 10(5):e033461. PubMed ID: 32371507
[TBL] [Abstract][Full Text] [Related]
13. Acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer: pilot study.
Oh B; Kimble B; Costa DS; Davis E; McLean A; Orme K; Beith J
Acupunct Med; 2013 Sep; 31(3):264-71. PubMed ID: 23722951
[TBL] [Abstract][Full Text] [Related]
14. Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer.
Campbell A; Heydarian R; Ochoa C; Dwivedi AK; Nahleh ZA
Breast J; 2018 May; 24(3):260-268. PubMed ID: 29442401
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness, safety, and economic evaluation of adjuvant moxibustion therapy for aromatase inhibitor-induced arthralgia of postmenopausal breast cancer stage I to III patients: Study protocol for a prospective, randomized, assessor-blind, usual-care controlled, parallel-group, pilot clinical trial.
Shin S; Jang BH; Park SH; Lee JW; Chae MS; Kim N; Suh HS; Han S; Min SY; Baek SK; Lim YJ; Hwang DS
Medicine (Baltimore); 2019 Sep; 98(38):e17260. PubMed ID: 31568000
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer.
Greenlee H; Crew KD; Shao T; Kranwinkel G; Kalinsky K; Maurer M; Brafman L; Insel B; Tsai WY; Hershman DL
Support Care Cancer; 2013 Apr; 21(4):1077-87. PubMed ID: 23111941
[TBL] [Abstract][Full Text] [Related]
17. Acupoint Thread Embedding Combined With Wenshen Bugu Decoction for the Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptom Among Postmenopausal Breast Cancer Patients: Study Protocol of a Randomized Controlled Trial.
Zou X; Chen ZY; Yang YH; Qiao Y; He SJ; Li Q; Chen WL; Zhang XY; Li SY; Sha SY; Hu MH; Zhang XY; Yang MJ; Wang RP; Wu HG; Shi Y; Xue XH; Ji YJ
Integr Cancer Ther; 2023; 22():15347354231188679. PubMed ID: 37565358
[TBL] [Abstract][Full Text] [Related]
18. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
Roberts KE; Adsett IT; Rickett K; Conroy SM; Chatfield MD; Woodward NE
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013167. PubMed ID: 35005781
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
Gnant M; Pfeiler G; Dubsky PC; Hubalek M; Greil R; Jakesz R; Wette V; Balic M; Haslbauer F; Melbinger E; Bjelic-Radisic V; Artner-Matuschek S; Fitzal F; Marth C; Sevelda P; Mlineritsch B; Steger GG; Manfreda D; Exner R; Egle D; Bergh J; Kainberger F; Talbot S; Warner D; Fesl C; Singer CF;
Lancet; 2015 Aug; 386(9992):433-43. PubMed ID: 26040499
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study).
Chan A; De Boer R; Gan A; Willsher P; Martin R; Zissiadis Y; Miller K; Bauwens A; Hastrich D
Support Care Cancer; 2017 Dec; 25(12):3785-3791. PubMed ID: 28691132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
